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Summary A monoclonal antibody, FBT3, was raised against Tn positive erythrocytes and, using immuno-
histochemistry, fresh and fixed tissues from patients with cancer were studied to detect any expression of a
Tn-like epitope. Expression was found in neoplastic cells, usually both in cytoplasm and on cell membranes,
from 104 of 147 cases of carcinoma and 1 of 13 cases of lymphoma, but rarely in adjacent, morphologically
normal cells. Tn expression was seen in some normal glandular cells but, unlike cancer cells, it was distributed
as fine granules in a supranuclear position. Detection of a Tn-like epitope is of theoretical interest and may
be of direct diagnostic value.
Alpha sialoglycoprotein (synonym glycophorin A) is an
important constituent of the membrane of erythroid cells
and is responsible for the antigenic determinants of the
erythrocyte MN blood group system (Issitt, 1981). The
molecule consists of a polypeptide chain to which are
attached a number of sugar residues and one or more
terminal sialic acid molecules. Sialoglycoprotein bears two
cryptic antigenic determinants termed T and Tn and all
individuals have in their plasma anti-T and anti-Tn anti-
bodies which are thought to develop in response to organ-
isms of their intestinal flora which bear related antigens.
Removal of the terminal sialic acid of sialoglycoprotein in
erythrocytes leads to uncovering of the T antigen; this is not
uncommon and is usually due to bacterial infection and the
activity of bacterial neuraminidase. Lack of the penultimate
residue, galactose (and the terminal sialic acid) leads to
uncovering of the Tn antigen. Biochemically, Tn antigen
expression corresponds to exposure of N-acetyl-D-galacto-
samine residues 0-glycosidically linked to serine or
threonine.
Tn expression is thought to be rare and has been reported
in a few cases of malignant or premalignant haemopoietic
disorders in which its presence has been detected following
observation of polyagglutination of the erythrocytes by all
blood grouping antisera. In these conditions the appearance
of Tn appears to be due to a deficiency of the enzyme, 3-,B-
D-galactosyl transferase which appears to result from a
somatic mutation at the gene locus for this enzyme (Cartron
et al., 1978).
As part of a study into the importance of somatic
mutation in human cells, we investigated whether uncovering
of Tn would be a useful marker for somatic mutation in a
variety of cell types. To this end a number of monoclonal
antibodies were produced against the Tn epitope and tested
against a variety of normal and malignant cells. Early in the
course of this study we became aware of the work of
Springer et al. on the expression of T and Tn antigens in
cancer (Springer et al., 1979; Springer, 1984; Springer et al.,
1985a). In extensive studies using polyclonal antibodies they
have shown that the T antigen is often expressed in cases of
cancer, particularly breast cancer; in more limited studies,
principally using antibody absorption, they have found that
the Tn antigen may also be expressed in some instances.
Recently Hirohashi et al. (1985) have observed that Tn
specificity is shown by two monoclonal antibodies which
were raised by immunization with lung cancer cells and
which react with human cancer tissues.
In this paper we report results using one of the panel of
monoclonal antibodies directed against the Tn epitope. The
results indicate that expression of Tn is a common




Tn positive erythrocytes were obtained from a number of
patients showing the polyagglutination phenomenon and the
Tn phenotype of the erythrocytes was confirmed by reaction
with a variety of plant lectins, particularly, Salvia sclarea
which is specific for Tn (Bird & Wingham, 1973). Male
BALB/c mice were injected intraperitoneally at intervals of
three weeks with 0.2ml of a 5% suspension of Tn positive
erythrocytes and a booster dose of antigen was given 4 days
prior to hybridoma formation which was carried out using
previously described techniques (Hurrell, 1982). The spleen
cells from the immunized mice were fused with the mouse
myeloma cell line P3.X63.Ag8 and supernatants of hybrids
which had grown were screened against Tn positive and
negative erythrocytes using haemagglutination and indirect
fluorescence. Positive antibody producing hybrids were sub-
cloned twice by limiting dilution and the resultant clones
screened for production of anti-Tn antibodies by demon-
strating reactivity against 7 examples of Tn positive erythro-
cytes and lack of reactivity against Tn negative erythrocytes
which showed ABO, Rh, Ii, Fy, K, MNS, P, Lu, Jk, Le,
Xg, Wr, En(a-), Mg+, SD+, Sd(a++), St(a+), and T blood
group specificities. From 6 anti-Tn clones one, FBT3, was
selected to be further characterized and to be used in
immunohistochemical studies because of its very avid
reactivity with Tn positive erythrocytes. Isotyping of FBT3
by an immunodot blot technique (McDougal et al., 1983)
using monospecific antisera showed it to be of the IgM class.
SDS-polyacrylamide-gel electrophoresis of erythrocyte mem-
branes and immunoblotting was carried out using previously
established techniques (Merry et al., 1986). Haemagglutin-
ation inhibition studies were performed on culture super-
natant as previously described (Springer et al., 1985b).
Immunohistochemistry
Tissue was obtained from fresh surgical specimens,
embedded and frozen in OCT medium (Tissue-Tek, Miles
Laboratories, USA) and stored at -80°C prior to use. The
storage interval varied between 2h and 10 months. Adjacent
blocks of tissue were fixed in 4% formaldehyde in phosphate
buffer (pH7.0) and processed to paraffin blocks for routine
histopathological assessment. Material was available from a
variety of cases of carcinoma as shown in Table I. There
were also 12 cases of non-Hodgkin's lymphoma, 1 of
Hodgkin's lymphoma, and 10 reactive lymph nodes.
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aDiffuse cell membrane and/or cytoplasmic staining.
The working solution of FBT3 was a 1:100 dilution of the
hybridoma culture supernatant in TRIS-saline buffer, pH7.6,
and had a protein concentration of 0.05 pgml-1. All tissues
were stained using a modification of the indirect Avidin-
Biotin-Complex (ABC) technique of Hsu et al. (1981) which
was modified by the addition of 8% NiCl2 to the final
diaminobenzidine (DAB)/H202 solution. This modification
produces a final staining which is black in colour and of
greater intensity than DAB alone. The sections were then
counterstained in chloroform extracted methyl green which
imparts a clear green colour to the nuclei. As a negative
control the sections were stained with HO-2.2 an IgM
antibody which is directed against the Lyt-2.2 murine T-
lymphocyte differentiation antigen and which is also derived
from the P3.X63.Ag8 fusion line. Sections from a specimen
of gastric carcinoma known to react with FBT3 were
included with each batch of unknowns as a positive control.
The results were assessed and scored by two independent
observers. A positive result was recorded when dense
brown/black staining was seen over defined cytological
structures.
Results
Monoclonal antibody FBT3 was shown to react specifically
with Tn positive erythrocytes, by haemagglutination and
indirect fluorescence testing. Minimal haemagglutination in-
hibition was found with N-acetyl-D-galactosamine. Specificity
of this antibody was further demonstrated by immuno-
blotting. Figure 1 shows the immunoblot of FBT3
against normal and Tn erythrocyte membrane proteins.
Binding to a, 6 and dimers of a and sialoglycoproteins in
Tn positive erythrocytes was observed with FBT3, but none
was evident with normal erythrocytes.
The overall immunohistochemical findings are shown in
AppendixFigure 2 Normal colonic mucosa (frozen section) x 1,000.
Granular Tn staining is seen in some goblet cells in a supra-
nuclear position (arrowed). Cell membranes are not stained.
(a) (b) (c)
Figure 1 Reaction of FBT3 with membrane proteins separated
by SDS/polyacrylamide-gel electrophoresis from normal and Tn
erythrocytes [(a) Tn membranes, (b) membranes from normal A
erythrocytes, (c) membranes from normal group 0 erythrocytes].
Table I and examples are shown in Figures 2 and 3. Fine
granular supranucleur staining was seen in some normal
glandular epithelia (Figure 2 and Table I). This staining
corresponded to the region of the Golgi apparatus and was
clearly different from that seen in cancer cells. By contrast,
staining of neoplastic cells was intense and was distributed
both on the cell membrane and within the cytoplasm,
sometimes being greater in the perinuclear region. Frozen
tissue tended to stain slightly more strongly than formalin-
fixed tissue. Non-malignant mucosa immediately adjacent to
gastrointestinal tumours showed occasional positive staining
on the luminal border of cells but elsewhere the normal
mucosa was negative apart from punctate staining as
described above. In one case of gastric carcinoma the gastric
carcinoma was strongly positive and a concomitant
leiomyoma was negative.
Examination of normal lymphoid tissues showed faint
staining of dendritic-like processes of some cells. This was
seen in 6 of 10 normal reactive nodes, 3 of 12 cases of non-
Hodgkin's lymphoma but not in the one case of Hodgkin's
disease studied. Diffuse staining of large blast cells was seen
in 1 of the 12 cases of non-Hodgkin's lymphoma.
Discussion
The present study used a monoclonal antibody raised against
the Tn epitope on erythrocytes and a sensitive immunohisto-
chemical technique to demonstrate that an epitope the same
Figure 3 Carcinoma of breast (frozen section) x 250. There is an
infiltrate of poorly differentiated carcinoma. Stained for Tn
(modified ABC technique) surrounding a normal breast duct
(arrowed). The predominant staining here is cytoplasmic.
as or similar to the Tn epitope can be expressed by
malignant cells. The antigen was detected both on the
surface and within the cytoplasm and, by contrast with
many other tumour associated antigens, positive staining was
usually quite intense and background staining insignificant.
This adds to the usefulness of the antigen as a tumour
marker.
The expression of T and Tn in tumours has previously
been studied by Springer et al. (1979; 1983; 1985a, b). Most
of their studies have involved expression of the T antigen,
which has been found to be frequently expressed by cancer
cells. More recently, they have shown that Tn may also be
expressed by cancer cells. In the studies of Tn they princi-
pally used absorption of polyclonal human anti-Tn by tissue,
decrease in antibody titre as their assay, and studied breast
cancer as the prototypic cancer. They carried out limited
studies using immunohistochemistry to detect binding of
polyclonal human anti-Tn and reported that normal cells
either did not stain or stained weakly whereas tumour cells
stained much more intensely. They raised monoclonal anti-
bodies to Tn using breast cancer tissue as the immunogen
and, using histochemistry, they noted that 3 of 5 breast
cancers showed positive staining, and that normal structures
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showed less, although often some, staining (Springer et al.,
1985a). Hirohashi et al. (1985) characterized as Tn two
monoclonal antibodies raised against cancer cells and indi-
cated that they labelled neoplastic tissues from cancer
patients but not the corresponding normal tissues from
normal individuals.
The present study used a monoclonal antibody raised
against Tn positive erythrocytes and the results using this
antibody showed that 104 of 147 cases of cancer were
positive. We have no proof that in cancer cells the antibody
was detecting the Tn epitope; it may have been detecting a
closely related structure but the term Tn is used for con-
venience. Expression of Tn was not confined to a single
type of epithelial cancer. Staining of the non-neoplastic
'normal' cells adjacent to the tumour was not seen. However,
fine supra-nuclear punctate staining was seen in some normal
glandular cells (Figure 2 and Table I), but the appearance
was quite different from that seen in malignancy (Figure 3).
The findings in lymphomas and lymphoid tissue differed
from those for epithelial tumours. Staining of dendritic
processes was seen in normal and reactive lymph nodes, but
diffuse cell staining was seen in only 1 case and some
lymphomas.
The importance of Tn with respect to tumour biology and
the relationship between tumour and host remains to be
determined. It is possible that expression of Tn may be an
epiphenomenon of little basic importance but several obser-
vations suggest that this may not be the case. The fact that
the Tn epitope is observed on carcinoma cells arising from a
variety of different tissues indicates that the epitope is not
tissue specific but may have a wider importance. Cells
expressing Tn on their membrane show alterations in surface
charge and adhesiveness (Springer et al., 1983) and such
alterations could be involved in the ability of malignant cells
to infiltrate and metastasize. Normal individuals can mount
an immune reaction against Tn, which raises the possibility
that expression of Tn may influence the interaction between
tumour and host. Leukaemic cells may show expression of
Tn and we have observed two patients, one with acute
myeloid leukaemia in whom Tn positive cells could not be
detected at initial presentation but gradually increased in
number as the disease progressed until the whole leukaemic
population was Tn positive at final relapse (Roxby et al.,
1986) and the other with myelodysplasia in whom a clone of
Tn positive cells is gradually increasing in number. These
findings could be' interpreted as indicating a relationship
between Tn expression and disease progression.
Irrespective of any more fundamental importance of the
expression of Tn, the present results raise the possibility that
it may provide a valuable diagnostic marker for carcinoma
cells. Whether this type of application will be feasible is
uncertain and will depend on the results of study of archival
material and of material from pre-neoplastic tissues in
addition to neoplastic and normal tissues. Both these
applications are the subject of further investigation.
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